HIGHLIGHTS
- who: Theerachai Thammathiwat et al. from the Division of Nephrology, Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand have published the research: Membranous Nephropathy following Full-Dose of Inactivated SARS-CoV-2 Virus Vaccination: A Case Report and Literature Review, in the Journal: Vaccines 2023, 11, 80. of /2023/
SUMMARY
Of 9 linked to the 2019-nCoV-BetaCoV Wuhan/WIV04/2019. Of phase 3 trials have shown that the inactivated viral vaccine has a high efficacy rate of 51-84% and a good safety profile. Glomerular diseases following SARS-CoV-2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.